IP Library Granted Patent US 8,221,799
Granted Patent B2
US 8,221,799 · App. 11/671,317 · Granted Jul 17, 2012

Multiple antioxidant optimal health/veterans ultimate complete formulations

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,221,799
App. No.
11/671,317
Granted
Jul 17, 2012
Kind
B2
Abstract

The invention is directed to a method for administering antioxidant micronutrient formulations comprising multiple dietary and endogenous antioxidants, B-vitamins, vitamin D and minerals at appropriate dosages and dose schedules particularly chosen to produce long-term ‘optimal health’ effects in individuals of various age groups and occupations, with particular emphasis on reducing and/or eliminating acute and/or long term effects of environmental and physical stressors and toxic chemicals to which current Operating Forces and veterans of military service are or have been exposed.

Claims (68)

1. An antioxidant micronutrient formulation consisting of:

Vitamin A (Palmitate)

3000-5000

IU

Natural Vitamin E

(d-alpha Tocopheryl Succinate - 50-600 IU)

(d-alpha Tocopheryl Acetate - 50-200 IU)

Vitamin C (Calcium Ascorbate*)

100-4000

mg

(*22 mg of Vitamin C is provided by Niacinamide

Ascorbate)

Vitamin D-3 (Cholecalciferol)

200-600

IU

Vitamin B-1 (Thiamine Mononitrate)

1-10

mg

Vitamin B-2 (Riboflavin)

1-20

mg

Vitamin B-3 (Niacinamide Ascorbate*)

10-60

mg

Vitamin B-6 (Pyridoxine Hydrochloride)

1-10

mg

Folic Acid

200-2000

mcg

Vitamin B-12 (Cyanocobalamin)

5-30

mcg

Biotin

100-1600

mcg

Pantothenic Acid (as D-Calcium Pantothenate)

5-30

mg

Calcium Citrate

100-500

mg

Magnesium Citrate

50-250

mg

Zinc Glycinate

10-60

mg

Selenium (Seleno-L-Methionine)

50-250

mcg

Chromium (as Chromium Picolinate)

25-250

mcg

N-Acetyl Cysteine (NAC)

100-500

mg

Coenzyme Q10

10-300

mg

R-alpha Lipoic Acid

25-250

mg

L-Carnitine

50-500

mg

wherein said formulation is used by military personnel and veterans.

2. The formulation of claim 1 wherein said formulation is consumed by a user at least twice per day.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Mar 23, 2022
From: JGB COLLATERAL, LLC
To: NABC, INC.
Reel/Frame 059383/0122 →
RELEASE OF SECURITY INTEREST Recorded Dec 22, 2020
From: EAST WEST BANK
To: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.; MORINDA, INC.
Reel/Frame 054733/0587 →
RELEASE OF SECURITY INTEREST Recorded Dec 7, 2020
From: EAST WEST BANK
To: NEWAGE, INC.; NABC, INC.; MORINDA, INC.
Reel/Frame 054560/0232 →
SECURITY INTEREST Recorded Dec 1, 2020
From: ARIEL MERGER SUB 2, LLC; NEWAGE, INC. (A WASHINGTON CORPORATION); NABC, INC.; MORINDA, INC.
To: JGB COLLATERAL, LLC (A DELAWARE LIMITED LIABILITY COMPANY)
Reel/Frame 054509/0837 →
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2019
From: DOMINION CAPITAL LLC
To: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.
Reel/Frame 048793/0288 →
SECURITY INTEREST Recorded Apr 1, 2019
From: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.; MORINDA, INC.
To: EAST WEST BANK
Reel/Frame 048752/0082 →
RELEASE OF SECURITY INTEREST Recorded Apr 1, 2019
From: SIENA LENDING GROUP LLC
To: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.
Reel/Frame 048752/0034 →
SECURITY INTEREST Recorded Aug 13, 2018
From: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES CORPORATION
To: SIENA LENDING GROUP LLC
Reel/Frame 046623/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2018
From: PREMIER MICRONUTRIENT CORPORATION
To: NEW AGE HEALTH SCIENCES, INC.
Reel/Frame 046599/0450 →
SECURITY INTEREST Recorded Jun 22, 2018
From: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.
To: DOMINION CAPITAL LLC
Reel/Frame 046181/0389 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2007
From: PRASAD, KEDAR N.; HAASE, GERALD M.; COLE, WILLIAM C.
To: PREMIER MICRONUTRIENT CORPORATION
Reel/Frame 019153/0303 →